Evidence map›Paper›PMID 11083883›Full record

GuidelineThorax2000

Smoking cessation guidelines for health professionals: an update. Health Education Authority.

R West, A McNeill, M Raw

Registry-linked trialOpen access · bronzeAbstract readGuidelinePractice Guideline
In one paragraph

Guideline in Thorax, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02195739 (A Retrospective, Real-life Evaluation of the Cardiovascular Disease Risk Associated With Exposure to Pharmacological Smoking Cessation Interventions in a Representative UK Primary Care Patient Population.), which is not on this map. Cited by 217 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
217citing papers in PubMed, 14 pooled it
29.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02195739 unknown statusnot on this mapstarted 2013, after this paper: background citation

A Retrospective, Real-life Evaluation of the Cardiovascular Disease Risk Associated With Exposure to Pharmacological Smoking Cessation Interventions in a Representative UK Primary Care Patient Population.

TypeobservationalSponsorResearch in Real-Life LtdRan2013 to 2014Enrolled61,050ConditionsSmoking Cessation
3 · Its place in the literature

Who cites it

217 citing papers in PubMed, 14 syntheses or guidelines pooled it, 986 citations in OpenAlex.

  1. Pooled it
  2. Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Pooled it
  4. Biomedical risk assessment as an aid for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Smoking cessation for people with chronic obstructive pulmonary disease.The Cochrane database of systematic reviews · 2016
    Pooled it
  8. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2014
    Pooled it
  9. Physician advice for smoking cessation.The Cochrane database of systematic reviews · 2013
    Pooled it
  10. Pooled it
  11. Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2010
    Pooled it
  12. Pooled it
  13. The feasibility of smoking reduction: an update.Addiction (Abingdon, England) · 2005
    Pooled it
  14. Guideline
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

157 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R WestSt George's Hospital Medical School, University of London, London SW17 0RE, UK.
A McNeill
M Raw
University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper updates the evidence base and key recommendations of the Health Education Authority (HEA) smoking cessation guidelines for health professionals published in Thorax in 1998. The strategy for updating the evidence base makes use of updated Cochrane reviews supplemented by individual studies where appropriate. This update contains additional detail concerning the effectiveness of interventions as well as comments on issues relating to implementation. The recommendations include clarification of some important issues addressed only in general terms in the original guidelines. The conclusion that smoking cessation interventions delivered through the National Health Service are an extremely cost effective way of preserving life and reducing ill health remains unchanged. The strategy recommended by the guidelines involves: (1) GPs opportunistically advising smokers to stop during routine consultations, giving advice on and/or prescribing effective medications to help them and referring them to specialist cessation services; (2) specialist smokers' services providing behavioural support (in groups or individually) for smokers who want help with stopping and using effective medications wherever possible; (3) specialist cessation counsellors providing behavioural support for hospital patients and pregnant smokers who want help with stopping; (4) all health professionals involved in smoking cessation encouraging and assisting smokers in use of nicotine replacement therapies (NRT) or bupropion where appropriate. The key points of clarification of the previous guidelines include: (1) primary health care teams and hospitals should create and maintain readily accessible records on the current smoking status of patients; (2) GPs should aim to advise smokers to stop, and record having done so, at least once a year; (3) inpatient, outpatient, and pregnant smokers should be advised to stop as early as possible and the advice recorded in the notes in a readily accessible form; (4) there is currently little scientific basis for matching individual smokers to particular forms of NRT; (5) NHS specialist smokers' clinics should be the first point of referral for smokers wanting help beyond what can be provided through brief advice from the GP; (6) help from trained health care professionals specialising in smoking cessation such as practice nurses should be available for smokers who do not have access to specialist clinics; (7) the provision of specialist NHS smokers' clinics should be commensurate with demand; this is currently one or two full time clinics or their equivalent per average sized health authority, but demand may rise as publicity surrounding the services increases.

Indexed as

Behavior TherapyBupropionEvidence-Based MedicineFamily PracticeFemaleHumansNational Health ProgramsNicotinePatient Education as TopicPregnancySmoking CessationState MedicineUnited KingdomBupropionNicotine

Identifiers

PMID11083883
PMCPMC1745657
OpenAlexW2163537767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.